There is no European plan to address in the short-term the regulatory barriers for the use of cannabis for medicinal purposes, the Council presidency of the EU and the European Commission have confirmed to EURACTIV.
Contacted by this website, a diplomatic source said that although therapeutical cannabis is certainly an important topic, at the moment no work is planned on this dossier during the German EU presidency, which runs until the end of the year.
Expectations to address medicinal cannabis at the EU level were high before the start of Berlin’s presidency, as Germany is currently the most-advanced European market for hemp products for therapeutic purposes.
After having passed a reform of the country’s drugs law in 2017, Germany paved the way for other EU countries to develop policies for granting patients easier access to medical marijuana.
The Czech Republic, Italy, Malta, the Netherlands and the United Kingdom are among the other member states which have…